The stratum corneum is roughly the thickness of a red blood cell — a 15-micron mosaic of dead corneocytes stacked in a lipid matrix. It is the reason topical medicine is difficult. Everything Xhealth develops is a negotiation with this layer: how to cross it, how to stay in it, how to leave it undamaged.
Mucopolysaccharide polysulfate is a semi-synthetic glycosaminoglycan built from polysulfated chondroitin. It has been used clinically for over five decades — for bruises, superficial thrombophlebitis, xerosis, atopic dermatitis and post-inflammatory dryness — and it is the pharmacological backbone of Hirudiox®.
Mucopolysaccharide polysulfate is not a single-action molecule. Its densely-sulphated glycosaminoglycan backbone interacts with multiple dermal systems at once — coagulation, inflammation, hydration and vascular function.
Cutaneous blood flow (CBF) is regulated through dermal papillary loops — arterial capillaries that supply nutrients and clear metabolites. When CBF is impaired, so is thermoregulation, wound healing, and the skin's response to injury.
Laser-Doppler studies show that topically-applied MPS increases local skin blood volume and basal sweating — evidence that a molecule >500 Da can, in fact, reach the dermis and act on its cells.
This is why MPS-containing topicals are clinically effective for conditions rooted in vessel-function failure: bruising, superficial thrombophlebitis, asteatosis, chronic venous discomfort, and the ageing skin's slow retreat from its own microcirculation.
A solution poured onto scalp will run off. A cream will smear the hair and refuse to reach the follicle. A fast-breaking foam — a low-viscosity liquid that expands into a bubble matrix on contact with warmth, then collapses in 30–60 seconds — solves both problems at once.
Foam permeation depends on three physical parameters: surface tension, evaporation kinetics, and the diffusion coefficient of the active in the residue phase. In our proprietary Xcare vehicle, these three are tuned so that minoxidil precipitates as a supersaturated film on the scalp — a driving force that pushes molecules through the corneum without the propylene glycol that irritates so many patients.
The clinical consequence is unglamorous but important: patients actually apply it. In the pharmacology of hair loss, adherence is half the battle, and vehicle design is where that battle is won.